Search Results 701-710 of 15983 for Residual
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...
The implants used in hip replacements are made to resist corrosion and wear. For most people who undergo the surgery, hip replacement successfully relieves hip ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Mayo Clinic's simple, healthy low-fiber recipes support a long-term nutrition plan helping with digestion and abdominal health.
... residual colon/rectum/pouch as the primary disease site. Transforming Healthcare and Outcomes for Children with Inflammatory Bowel Disease. La Crosse, Wis ...
Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
- To evaluate residual effect in follow up. - To evaluate the safety of dupilumab in patients with bilateral NP. - To evaluate functional dupilumab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.